See also this year's filing and all EDGAR filings for this company.
PDF Report 0001082554_2017_United_Therapeutics_Corp.pdf
Logs
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001082554, United Therapeutics Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,424,800,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 489,300,000 |
| 3 | remainder_Assets | 411,500,000 |
| 4 | LiabilitiesCurrent | 332,500,000 |
| 5 | LiabilitiesNoncurrent | 130,900,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 336,860,672 |
| 9 | ResearchAndDevelopmentExpense | 159,032,658 |
| 10 | remainder_Expenses | 405,394,299 |
| 11 | remainder_Revenues | 1,705,334,210 |
| 12 | remainder_NetIncome | 303,407,913 |
| 13 | remainder_ComprehensiveNetIncome | 123,514 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,325,600,000 |
| 1 | Liabilities | 463,400,000 |
| 2 | Expenses | 901,287,629 |
| 3 | Revenues | 1,705,334,210 |
| 4 | StockholdersEquity | 1,862,200,000 |
| 5 | NetIncome | 1,107,454,494 |
| 6 | ComprehensiveNetIncome | 1,107,516,251 |
| 7 | BaseVar | 2,849,576,633 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.71 |
| 9 | EconomicCapitalRatio | 4.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
